Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000025 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
43,827
Total Value
$589,089.84
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Jul 1, 2026 | Exercise/Conversion | 14,609 | $10.42 | $152,225.78 | 14,609 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jul 1, 2026 | Sale | 13,409 | $29.86 | $400,459.78 | 1,200 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jul 1, 2026 | Sale | 1,200 | $30.34 | $36,404.28 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Jul 1, 2026 | Exercise/Conversion | 14,609 | $0.00 | $0.00 | 192,945 | Direct | โ | View Details |